Key facts
- This page summarizes Adam Tomasi's Form 4 filing for Allakos Inc. (ALLK).
- 8 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 15 May 2025, 16:08.
Adam Tomasi - 15 May 2025 Form 4 Insider Report for Allakos Inc. (ALLK)
- Reporting relationship
- President
- Issuer ticker
- ALLK
- Reported as of
- 15 May 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 15 May 2025, 16:08:04 UTC
- Prior SEC filing
- 07 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ H. Baird Radford, III, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Adam Tomasi filed Form 4 for Allakos Inc. (ALLK) on 15 May 2025.
Change
- Previous filing in this sequence was filed on 07 Mar 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001637219
Primary reporting owner
Tomasi Adam
- Relationship
- President
- Address
- 149 COMMONWEALTH DR, SUITE 1090, MENLO PARK
- Signature
- /s/ H. Baird Radford, III, by power of attorney
- Signature date
- 15 May 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALLK
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -512,630
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Footnotes
- F1, F2
ALLK
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -20,790
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- See footnote
- Footnotes
- F2, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALLK
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -486,400
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 486,400
- Exercise price
- $0.6900
- Footnotes
- F4
ALLK
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -145,011
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 145,011
- Exercise price
- $4.01
- Footnotes
- F4
ALLK
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -88,036
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 88,036
- Exercise price
- $4.31
- Footnotes
- F4
ALLK
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -125,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 125,000
- Exercise price
- $35.28
- Footnotes
- F4
ALLK
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -300,471
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 300,471
- Exercise price
- $7.20
- Footnotes
- F4
ALLK
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -1,200,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 15 May 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,200,000
- Exercise price
- $1.25
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Adam Tomasi is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
Includes 190,270 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.
Footnote F2
Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.
Footnote F3
The shares are held by Mr. Tomasi and Carrie Tomasi, as Trustees of the Tomasi Living Trust dated July 14, 2017.
Footnote F4
This option was cancelled without consideration pursuant to the terms of the Merger Agreement.